CD4 and cancer: Comparable frequencies of CD4+ and CD8+ Treg were detected in both types of cancer (Figure 2, panels E and F), although a predominance of either CD4+ Treg or CD8+ Treg was observed in different specimens (Figure 2, panels G and H).